Clinical Trial Update: Oxcarbazepine Plus Morphine in Patients With Refractory Cancer Pain [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating oxcarbazepine in combination with morphine for refractory cancer pain; the study status is TERMINATED.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• Morphine (morphine)
• Oxcarbazepine (Oxcarbazepine)

Snippet

Sponsor: Costantine Albany | Conditions: Cancer | Phase 1 | Status: TERMINATED